Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Open in API
Filings indexed 2,572 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2026-05-26 English
SD
Regulatory Filings Classification · 91% confidence The document is a U.S. SEC Form SD (Specialized Disclosure Report) disclosing conflict minerals sourcing for Illumina, Inc. It is a mandated compliance filing under Rule 13p-1, not an annual or quarterly report, earnings release, director dealing, proxy or sustainability report in the narrow sense. It serves as a regulatory compliance disclosure. There is no dedicated code for Form SD, so it falls under the fallback category “Regulatory Filings (RNS).”
2026-05-19 English
ARS - ILLUMINA, INC. (0001110803) (Filer)
Annual Report
2026-04-09 English
DEF 14A - ILLUMINA, INC. (0001110803) (Filer)
Proxy Solicitation & Information Statement
2026-04-09 English
8-K - ILLUMINA, INC. (0001110803) (Filer)
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 2, 2026, reporting the departure of directors and the nomination of a new director for the upcoming annual meeting. The key section is Item 5.02, which details the retirement of three directors and the nomination of a new director. This is a clear announcement of changes in the company's board of directors. The document also includes a press release attached as Exhibit 99.1 related to these board changes. There is no financial data or detailed management discussion, so it is not an Annual Report, Interim Report, or Management Report. It is not a proxy solicitation or voting results announcement. The primary content is about board membership changes, which fits the Board/Management Information category (MANG). The document length is under 5,000 characters but contains substantive information about board changes, not just a report publication announcement. Therefore, the correct classification is MANG with high confidence.
2026-04-02 English
SCHEDULE 13G/A - ILLUMINA, INC. (0001110803) (Subject)
Major Shareholding Notification
2026-03-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.